Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models

Chemoradiotherapy (CRT) with paclitaxel (PTX) and cisplatin (CP) is part of the standard of care for patients with locally advanced non-small cell lung cancer (NSCLC). Despite the high treatment intensity, many patients still develop local recurrence after treatment. Thus, there is a strong need to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Mater Chem B Mater Biol Med
Hlavní autoři: Tian, Jing, Min, Yuanzeng, Rodgers, Zachary, Au, Kin Man, Hagan, C. Tilden, Zhang, Maofan, Roche, Kyle, Yang, Feifei, Wagner, Kyle, Wang, Andrew Z.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576184/
https://ncbi.nlm.nih.gov/pubmed/28868145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C7TB01370A
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky